ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 33 filers reported holding ANTHERA PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $83,000 | -46.5% | 26,383 | -47.2% | 0.00% | -100.0% |
| Q2 2016 | $155,000 | -19.3% | 50,000 | -50.0% | 0.00% | 0.0% |
| Q3 2014 | $192,000 | +12.9% | 100,000 | +100.0% | 0.00% | 0.0% |
| Q2 2014 | $170,000 | +1.2% | 50,000 | 0.0% | 0.00% | -50.0% |
| Q1 2014 | $168,000 | -45.3% | 50,000 | -50.0% | 0.00% | 0.0% |
| Q4 2013 | $307,000 | -23.6% | 100,000 | 0.0% | 0.00% | -50.0% |
| Q3 2013 | $402,000 | – | 100,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,714,958 | $5,265,000 | 0.34% |
| Broadfin Capital, LLC | 766,329 | $2,353,000 | 0.31% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,691,857 | $5,194,000 | 0.27% |
| Perceptive Advisors | 431,456 | $1,325,000 | 0.16% |
| Rhenman & Partners Asset Management AB | 119,297 | $366,000 | 0.14% |
| Orbimed Advisors | 932,750 | $2,864,000 | 0.04% |
| Weiss Multi-Strategy Advisers LLC | 210,000 | $645,000 | 0.01% |
| Visium Asset Management, LP | 200,000 | $614,000 | 0.01% |
| MOORE CAPITAL MANAGEMENT, LP | 224,800 | $690,000 | 0.01% |
| Alyeska Investment Group, L.P. | 72,800 | $223,000 | 0.01% |